First Wave BioPharma Inc (NASDAQ:FWBI)
| 0.2415 Delayed Data As of Nov 29 |  +0.01 / +4.35%Today’s Change | 0.22 Today|||52-Week Range 8.96 | -96.06% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 201.5K | 196.9K | 193.7K | 194.2K | ||
| Operating Expenses | Gross Income | -201.5K | -196.9K | -193.7K | -194.2K | |
| General Expenses | 2.9M | 2.3M | 3.9M | 4.4M | ||
| Research And Development | 925.8K | 1.2M | 1.2M | 2.1M | ||
| Total Operating Expenses | 3.1M | 2.5M | 4.0M | 4.6M | ||
| Non-Operating Expenses | Operating Income | -3.1M | -2.5M | -4.0M | -4.6M | |
| Extraordinary Credit | 0.00 | 0.00 | 30.0K | 0.00 | ||
| Extraordinary Charge | -170.0K | -80.0K | 0.00 | 0.00 | ||
| Interest Expense On Debt | 46.2K | 5.6K | 1.4K | 57.1K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -3.3M | -2.6M | -4.0M | -4.7M | |
| Net Income | -3.3M | -2.6M | -4.0M | -4.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 15.3M | 16.9M | 17.7M | 17.7M | |
| Shares To Calculate EPS Diluted | 15.3M | 16.9M | 17.7M | 17.7M | ||
| Earnings Per Share | EPS | -$0.22 | -$0.15 | -$0.24 | -$0.26 | |
| EPS Diluted | -$0.22 | -$0.15 | -$0.23 | -$0.26 | ||
